Aducanumab: What About the Patient?; Risk of Aneurysm Rupture After Stroke Thrombolysis
Neurology® Podcast
00:00
Patient and Caregivers Perspectives on Agicanuab
The circuitous path that aducanm has taken to accelerated approval is unusual and raises all oor eyebrows. I think on what we're talking about here is this familiar concept of shared decision making. The principle that exemplifies that we, when making a decision, need to solicit and encourage our patient and caregiver to share their perspective surrounding treatment.
Transcript
Play full episode
